EGFR and non-small cell lung carcinoma: In addition, Finocchiaro et al. have suggested the role of TGFB as a mediator of the intrinsic resistance to EGFR tyrosine kinase inhibitors in non-small cell lung cancer (NSCLC) patients (26).